Emergent BioSolutions (EBS) Misses Q3 EPS by $2.71
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.59 +2.23%
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Provision for (benefit from) income taxes: 13.17M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of ($0.36), $2.71 worse than the analyst estimate of $2.35. Revenue for the quarter came in at $329 million versus the consensus estimate of $486.84 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
